Invesco Ltd. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 25 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$482,978
+3.4%
250,0000.0%0.00%
Q4 2022$467,000
+12.0%
250,0000.0%0.00%
Q3 2022$417,000
+33.2%
250,0000.0%0.00%
Q2 2022$313,000
-4.6%
250,0000.0%0.00%
Q1 2022$328,000
-10.4%
250,0000.0%0.00%
Q4 2021$366,000
-1.1%
250,0000.0%0.00%
Q3 2021$370,000
+12.1%
250,0000.0%0.00%
Q2 2021$330,000
+0.9%
250,0000.0%0.00%
Q1 2021$327,000
-95.8%
250,000
-92.1%
0.00%
-100.0%
Q4 2020$7,772,000
+18.2%
3,170,0000.0%0.00%0.0%
Q3 2020$6,573,000
-32.5%
3,170,000
-25.2%
0.00%
-33.3%
Q2 2020$9,731,000
+51.2%
4,240,0000.0%0.00%0.0%
Q1 2020$6,436,000
-22.0%
4,240,0000.0%0.00%0.0%
Q4 2019$8,247,000
+114.5%
4,240,000
+45.7%
0.00%
+200.0%
Q3 2019$3,845,000
-56.9%
2,910,000
-27.4%
0.00%
-50.0%
Q2 2019$8,926,000
-2.7%
4,010,000
-21.1%
0.00%
-33.3%
Q1 2019$9,175,0005,085,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 8,907,000$17,329,4591.40%
CSS LLC/IL 7,106,000$13,798,2180.91%
Aequim Alternative Investments LP 5,000,000$9,672,0550.31%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,948,000$11,571,0450.23%
PALISADE CAPITAL MANAGEMENT, LP 2,051,000$3,989,1950.11%
CAPSTONE INVESTMENT ADVISORS, LLC 7,080,000$13,695,6320.07%
Point72 Asset Management, L.P. 9,007,000$17,447,3710.05%
SSI INVESTMENT MANAGEMENT LLC 257,000$496,5000.04%
LORD, ABBETT & CO. LLC 3,097,000$5,9830.02%
D. E. Shaw & Co., Inc. 4,100,000$7,953,1920.01%
View complete list of SAREPTA THERAPEUTICS INC shareholders